Agmatine attenuates nicotine induced conditioned place preference in mice through modulation of neuropeptide Y system

作者：Kotagale Nandkishor R; Walke Sonali; Shelkar Gajanan P; Kokare Dadasaheb M; Umekar Milind J; Taksande Brijesh G^*

来源：Behavioural Brain Research, 2014, 262: 118-124.

DOI：10.1016/j.bbr.2014.01.004

• Nicotine
• CPP
• Agmatine
• Neuropeptide Y

The purpose of the present study was to examine the effect of agmatine on nicotine induced conditioned place preference (CPP) in male albino mice. Intra-peritoneal (ip) administration of nicotine (1 mg/kg) significantly increased time spent in drug-paired compartment. Agmatine (20 and 40 mg/kg, ip) co-administered with nicotine during the 6 days conditioning sessions completely abolished the acquisition of nicotine-induced CPP in mice. Concomitant administration of neuropeptide Y (NPY) (1 pg/mouse, icv) or [Leu(31), Pro(34)]-NPY (0.1 pg/mouse, icv), selective NPY Y1 receptor agonist potentiated the inhibitory effect of agmatine (10 mg/kg, ip) on nicotine CPP. Conversely, pretreatment with NPY Y1 receptor antagonist, BIBP3226 (0.01 ng/mouse, icy) blocked the effect of agmatine (20 mg/kg, ip) on nicotine induced CPP. In immunohistochemical study, nicotine decreased NPY-immunoreactivity in nucleus-accumbens shell (AcbSh), bed nucleus of stria terminalis, lateral part (BNST1), arcuate nucleus (ARC) and paraventricular nucleus (PVN). Conversely, administration of agmatine prior to the nicotine significantly reversed the effect of nicotine on NPY-immunoreactivity in the above brain nuclei. This data indicate that agmatine attenuate nicotine induced CPP via modulation of NPYergic neurotransmission in brain.

• 出版日期2014-4-1